Abrams M - Search Results

1

Executive dysfunction predicts nonresponse to fluoxetine in major depression.

Dunkin JJ, Leuchter AF, Cook IA, Kasl-Godley JE, Abrams M, Rosenberg-Thompson S. Dunkin JJ, et al. Among authors: abrams m. J Affect Disord. 2000 Oct;60(1):13-23. doi: 10.1016/s0165-0327(99)00157-3. J Affect Disord. 2000. PMID: 10940443 Clinical Trial.

2

Pretreatment neurophysiological and clinical characteristics of placebo responders in treatment trials for major depression.

Leuchter AF, Morgan M, Cook IA, Dunkin J, Abrams M, Witte E. Leuchter AF, et al. Among authors: abrams m. Psychopharmacology (Berl). 2004 Dec;177(1-2):15-22. doi: 10.1007/s00213-004-1919-2. Epub 2004 Jul 14. Psychopharmacology (Berl). 2004. PMID: 15252704 Clinical Trial.

3

Changes in prefrontal activity characterize clinical response in SSRI nonresponders: a pilot study.

Cook IA, Leuchter AF, Morgan ML, Stubbeman W, Siegman B, Abrams M. Cook IA, et al. Among authors: abrams m. J Psychiatr Res. 2005 Sep;39(5):461-6. doi: 10.1016/j.jpsychires.2004.12.002. J Psychiatr Res. 2005. PMID: 15992554 Clinical Trial.

4

Altered cerebral energy utilization in late life depression.

Cook IA, Leuchter AF, Uijtdehaage SH, Osato S, Holschneider DH, Abrams M, Rosenberg-Thompson S. Cook IA, et al. Among authors: abrams m. J Affect Disord. 1998 May;49(2):89-99. doi: 10.1016/s0165-0327(97)00192-4. J Affect Disord. 1998. PMID: 9609672

5

Neurophysiologic predictors of treatment response to fluoxetine in major depression.

Cook IA, Leuchter AF, Witte E, Abrams M, Uijtdehaage SH, Stubbeman W, Rosenberg-Thompson S, Anderson-Hanley C, Dunkin JJ. Cook IA, et al. Among authors: abrams m. Psychiatry Res. 1999 Mar 22;85(3):263-73. doi: 10.1016/s0165-1781(99)00010-4. Psychiatry Res. 1999. PMID: 10333379 Clinical Trial.

6

Prospective testing of a neurophysiologic biomarker for treatment decisions in major depressive disorder: The PRISE-MD trial.

Cook IA, Hunter AM, Caudill MM, Abrams MJ, Leuchter AF. Cook IA, et al. Among authors: abrams mj. J Psychiatr Res. 2020 May;124:159-165. doi: 10.1016/j.jpsychires.2020.02.028. Epub 2020 Feb 26. J Psychiatr Res. 2020. PMID: 32169689 Free PMC article.

7

Changes in brain function of depressed subjects during treatment with placebo.

Leuchter AF, Cook IA, Witte EA, Morgan M, Abrams M. Leuchter AF, et al. Among authors: abrams m. Am J Psychiatry. 2002 Jan;159(1):122-9. doi: 10.1176/appi.ajp.159.1.122. Am J Psychiatry. 2002. PMID: 11772700 Clinical Trial.

8

Early changes in prefrontal activity characterize clinical responders to antidepressants.

Cook IA, Leuchter AF, Morgan M, Witte E, Stubbeman WF, Abrams M, Rosenberg S, Uijtdehaage SH. Cook IA, et al. Among authors: abrams m. Neuropsychopharmacology. 2002 Jul;27(1):120-31. doi: 10.1016/S0893-133X(02)00294-4. Neuropsychopharmacology. 2002. PMID: 12062912 Clinical Trial.

9

Estrogen replacement therapy is associated with less progression of subclinical structural brain disease in normal elderly women: a pilot study.

Cook IA, Morgan ML, Dunkin JJ, David S, Witte E, Lufkin R, Abrams M, Rosenberg S, Leuchter AF. Cook IA, et al. Among authors: abrams m. Int J Geriatr Psychiatry. 2002 Jul;17(7):610-8. doi: 10.1002/gps.644. Int J Geriatr Psychiatry. 2002. PMID: 12112157

10

Cognitive and physiologic correlates of subclinical structural brain disease in elderly healthy control subjects.

Cook IA, Leuchter AF, Morgan ML, Conlee EW, David S, Lufkin R, Babaie A, Dunkin JJ, O'Hara R, Simon S, Lightner A, Thomas S, Broumandi D, Badjatia N, Mickes L, Mody RK, Arora S, Zheng Z, Abrams M, Rosenberg-Thompson S. Cook IA, et al. Among authors: abrams m. Arch Neurol. 2002 Oct;59(10):1612-20. doi: 10.1001/archneur.59.10.1612. Arch Neurol. 2002. PMID: 12374500

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

608 results

Search Page